| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Inovio Pharmaceuticals, Inc. (INO) has 11 insiders with recent SEC Form 4 filings, including 3 buys and 8 sells. INO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 86.6K | $116.1K | - | |
| CEO | 84.9K | $113.7K | - | |
| CFO | 26.1K | $35.0K | - | |
| Other | 18.1K | $24.2K | - | |
| Dir | 12.2K | $16.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2020 | Kies Peter73 | CFO | Sell | 35,000 | $26.50 | $927,500.00 | -22.7% | |
| Jun 22, 2020 | Humeau Laurent | Chief Scientific Officer | Sell | 19,467 | $14.70 | $286,164.90 | -23.5% | |
| May 20, 2020 | Benito Simon X80 | Director | Sale+OE | 8,750 | $15.95 | $139,594.00 | -14.5% | |
| May 11, 2020 | Weiner David B.82 | Director | Sell | 2,404 | $11.84 | $28,463.36 | -0.3% | |
| Mar 12, 2020 | Weiner David B.82 | Director | Sale+OE | 7,000 | $10.23 | $71,610.00 | -0.4% | |
| Mar 9, 2020 | Weiner David B.82 | Director | Sale+OE | 3,500 | $18.00 | $63,000.00 | -0.4% | |
| Jan 13, 2020 | Kim Jong Joseph | Chief Executive Officer | Buy | 22,500 | $3.11 | $69,975.00 | +2.1% | |
| Aug 30, 2019 | Humeau Laurent | Chief Scientific Officer | Buy | 4,500 | $2.22 | $9,990.00 | +9.8% | |
| Aug 1, 2019 | Weiner David B.82 | Director | Sell | 16,352 | $2.72 | $44,477.44 | -2.0% | |
| Jun 5, 2019 | Humeau Laurent | Chief Scientific Officer | Buy | 20,000 | $2.50 | $50,000.00 | +77.4% |